Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ERBB2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06221475
What this trial is testing

Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants

Who this might be right for
Advanced Non-small Cell Lung CancerEGFR MutationHER2 Mutation+1 more
Bayer 8
Testing effectiveness (Phase 2)UnknownNCT02535507
What this trial is testing

Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Tongji University 40
Not applicableStudy completedNCT02670577
What this trial is testing

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Who this might be right for
Breast Cancer
Agendia 481
Not applicableLooking for participantsNCT05396612
What this trial is testing

Role of the Immune Environment in Response to Therapy in Breast Cancer

Who this might be right for
Breast CancerER Positive Breast CancerHER2-negative Breast Cancer+1 more
Abramson Cancer Center at Penn Medicine 300
Testing effectiveness (Phase 2)Looking for participantsNCT04563507
What this trial is testing

Combined Immunotherapies in Metastatic ER+ Breast Cancer

Who this might be right for
Breast Cancer
Weill Medical College of Cornell University 102
Testing effectiveness (Phase 2)Looking for participantsNCT06778031
What this trial is testing

A Clinical Study of SHR-A1811 in the Treatment of HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer

Who this might be right for
HER2-positive Locally Advanced or Metastatic Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 54
Large-scale testing (Phase 3)Study completedNCT00333775
What this trial is testing

Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hoffmann-La Roche 736
Testing effectiveness (Phase 2)Active Not RecruitingNCT06109467
What this trial is testing

Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer

Who this might be right for
GastroEsophageal CancerGastric Cancer
H. Lee Moffitt Cancer Center and Research Institute 8
Testing effectiveness (Phase 2)Study completedNCT00958971
What this trial is testing

Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 43
Testing effectiveness (Phase 2)Study completedNCT00633464
What this trial is testing

Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

Who this might be right for
Triple Negative Locally Advanced Non-resectable Breast CancerMetastatic Breast Cancer
R-Pharm 79
Testing effectiveness (Phase 2)Ended earlyNCT01531764
What this trial is testing

BIBW 2992 (Afatinib) and Vinorelbine

Who this might be right for
Carcinoma Breast Stage IV
University of Magdeburg 2
Large-scale testing (Phase 3)Ended earlyNCT00912444
What this trial is testing

Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 102
Not applicableActive Not RecruitingNCT07448493
What this trial is testing

Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer

Who this might be right for
Gastric CancerEsophageal CancerBrain Metastases
Blokhin's Russian Cancer Research Center 230
Not applicableStudy completedNCT06975371
What this trial is testing

Real-World Outcomes of Patients With Metastatic Breast Cancer After Treatment With First-Line ET+CDK4/6i

Who this might be right for
Advanced/Metastatic HER2-negative Breast Cancer
Daiichi Sankyo 1,415
Testing effectiveness (Phase 2)UnknownNCT05111444
What this trial is testing

Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Who this might be right for
Gastric NeoplasmsGastroesophageal Junction Adenocarcinoma
Fudan University 65
Testing effectiveness (Phase 2)Looking for participantsNCT04481932
What this trial is testing

Trastuzumab Combined With Pyrrolidine and Chemotherapy for Locally HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Peking University 104
Testing effectiveness (Phase 2)Study completedNCT05163106
What this trial is testing

Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole

Who this might be right for
Breast CancerHER2-negative Breast CancerER-positive Breast Cancer+3 more
University Hospital, Akershus 85
Large-scale testing (Phase 3)Study completedNCT01041404
What this trial is testing

ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 584
Early research (Phase 1)Study completedNCT00906698
What this trial is testing

Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2

Who this might be right for
Neoplasms
Boehringer Ingelheim 55
Testing effectiveness (Phase 2)WithdrawnNCT05191004
What this trial is testing

Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC

Who this might be right for
Advanced Breast CancerMetastatic Breast CancerBreast Cancer+5 more
Nuvation Bio Inc.
Next Page